Roche's 'Steep' Spark Buyout Could Put These Gene Therapy Names In PlayInvestors Business Daily • 03/18/19
How Much Can Roche's Share Price Grow If Ocrevus Doubles Its Share In Multiple Sclerosis Market?Forbes • 03/13/19